@IdVilchez @AeschlimannJeff @wfwrighID @DrToddLee @BradSpellberg @davidvanduin https://t.co/dpOxOxFtX6 https://t.co/Nwzu9vT0zR https://t.co/Riw948ryLI https://t.co/j4pb7FMwWZ here's a few, my read from OM/enzyme experts is rel gets your ampc (CMY, etc) to
@jessecouk @OncIDPharmd @wfwrighID @DrToddLee @davidvanduin @JonathanRyderMD @transplantID @SarahTaimur @FfejNil @ClancyNeil I know we want to practice stewardship, but I just get a bit nervous with immunocompromised patients...still too young in the field
In Vitro Studies Evaluating the Activity of Imipenem in Combination With Relebactam Against Pseudomonas Aeruginosa https://t.co/9PdWdiJFI2
In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa. https://t.co/2Gfr2SI1fW
In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa. https://t.co/vZF5P2LHZs #cre #crkp
In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa. https://t.co/TpWK7k5Css
In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa https://t.co/Bq0CQ1VU0o